We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Iconic Labs Plc | LSE:ICON | London | Ordinary Share | GB00BRBJ3P08 | ORD GBP0.0001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 5.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Health & Allied Services,nec | 0 | 4.77M | 0.5697 | 0.09 | 418.58k |
Date | Subject | Author | Discuss |
---|---|---|---|
16/10/2023 16:33 | Furthermore Bi, You obviously "swing both ways "? As a trader !. | oliversanvil | |
16/10/2023 16:28 | I have borrowed prior to buying ICON and has come good! When next RNS released this will spike double.Could be tomorrow! OR m aybe not --T Traders will be punished. | oliversanvil | |
16/10/2023 16:21 | Doesn't sound like advice to me. | bionicdog | |
16/10/2023 16:12 | Mine are all paid for--Just some sound advice! | oliversanvil | |
16/10/2023 15:57 | If it's all the same to you . . . | bionicdog | |
16/10/2023 15:43 | Beg -steal -borrow to buy. | oliversanvil | |
16/10/2023 10:07 | Once this starts whooshing then we will see. GLA LTHers! | kemche | |
16/10/2023 08:29 | Good Morning ! | chinese investor | |
14/10/2023 23:21 | Everyone is waiting for the appointment of turnaround specialists with backing of banks (plural). I suspect this will happen before the end of September. | kemche | |
14/10/2023 09:03 | endeavor2/OliversAnv So far the subscriptions have been coming from the ICON as they access the EGHOS £3 million facility. Now that the prospectus has been published what you need to look out for are subscriptions coming from EGHOS and Linton Capital as they collect their £750k each from the company. | pwhite73 | |
13/10/2023 19:06 | Buy now before news breaks OliversAnvil. I see the idiot chinese investor has been using his many different log ins to vote the liar up 15 times. Even a dormouse could see through that idiot. | endeavor2 | |
13/10/2023 17:03 | Just buy some more! No need to waste your breathe ! | oliversanvil | |
13/10/2023 16:38 | 10p is a mere memory and.....a certain future ! | chinese investor | |
13/10/2023 16:20 | and plants the seed of doubt! | oliversanvil | |
13/10/2023 16:18 | Deal with the RNS of 31/03/2023 regarding conversion notes for EGHOS and Linton from 08/08/2023. | pwhite73 | |
13/10/2023 16:17 | But who pays him that's what needs to be exposed as he does not do it for nothing. | endeavor2 | |
13/10/2023 16:15 | PW is a professional deramper He or she knows the speil. | oliversanvil | |
13/10/2023 16:13 | It's a disgrace that ADVFN allow him to carry out this market manipulation by making up lies. | endeavor2 | |
13/10/2023 16:10 | Yep it is now a No Brainer OliversAnvil. it has taken Brad a long time but he has achieved what he set out to do. | endeavor2 | |
13/10/2023 16:09 | Does anyone know who pay pwhite for his lies ? | endeavor2 | |
13/10/2023 16:05 | They want your shares--No Brainer! PWhite is now making a killing by any further selling.! | oliversanvil | |
13/10/2023 15:29 | Liar pwhite read the RNS and stop tellling lies. RNS Number : 0919Q Iconic Labs PLC 13 October 2023 13 October 2023 Iconic Labs PLC ("Iconic" or the "Company") Announcement of the Completion of CVA Iconic Labs PLC (LSE: ICON) is pleased to announce that the Creditors Voluntary Arrangement ("CVA") has been completed and the relevant documents have been filed at and accepted by Companies House. Brad Taylor, Chief Executive Officer of Iconic Labs, commented: "The successful completion of the CVA marks an important step towards Iconic Labs' financial stability. Now that the CVA is discharged, Iconic Labs has removed historic debts and is well positioned to progress with growth opportunities and focus on its strategic goals. "We look forward to updating shareholders and the market on our further activity in due course." - Ends - | endeavor2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions